@techcrunch.com 11 months ago
11 investors predict a colorful, if difficult, future for psychedelic startups
@techcrunch.com 2 years ago
8 cannabis investors share their outlook on the European market in H1 2022
@techcrunch.com 2 years ago
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
@techcrunch.com 2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@tech.eu 2 years ago
Why biotech investors are attracted to Lithuania
@xconomy.com 3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com 4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com 5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@techcrunch.com 5 years ago
China is funding the future of American biotech
@xconomy.com 5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More